Physician profile
Donna Smith
NPI 1225389935
$906.60
in general payments reported to CMS, 2019-2025
14 companies · $16.13 in 2025
The $16.13 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.26 · 2021: $80.75 · 2022: $650 · 2023: $54.76 · 2024: $50.16 · 2025: $16.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $121.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $393.41 | 2022 | |
| Smith+Nephew, INC. | $134.03 | 2021-2023 | Evos Mini |
| Medartis INC. | $63.75 | 2022 | |
| Zimvie INC. | $51.98 | 2022 | |
| Stryker Corporation | $49.81 | 2022 | |
| Axogen | $43.47 | 2021-2022 | |
| Abbott Laboratories | $33.52 | 2024 | Proclaim |
| Endo USA, INC. | $32.77 | 2024-2025 | Xiaflex |
| Bard Access Systems, INC. | $24.64 | 2019 | |
| Integra Lifesciences Corporation | $20.70 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Pacira Therapeutics, INC. | $17.23 | 2019 | |
| Endo Pharmaceuticals INC. | $14.32 | 2021 | |
| Merck Sharp & Dohme LLC | $13.58 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.